These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9047158)

  • 1. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.
    Kuo PC; Johnson LB; Plotkin JS; Howell CD; Bartlett ST; Rubin LJ
    Transplantation; 1997 Feb; 63(4):604-6. PubMed ID: 9047158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.
    Rafanan AL; Maurer J; Mehta AC; Schilz R
    Chest; 2000 Nov; 118(5):1497-500. PubMed ID: 11083710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK; Bass NM; De Marco T; Merriman RB
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
    Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
    Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension.
    Schroeder RA; Rafii AA; Plotkin JS; Johnson LB; Rustgi VK; Kuo PC
    Transplantation; 2000 Aug; 70(3):548-50. PubMed ID: 10949204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension.
    Findlay JY; Plevak DJ; Krowka MJ; Sack EM; Porayko MK
    Liver Transpl Surg; 1999 Sep; 5(5):362-5. PubMed ID: 10477835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol.
    Tan HP; Markowitz JS; Montgomery RA; Merritt WT; Klein AS; Thuluvath PJ; Poordad FF; Maley WR; Winters B; Akinci SB; Gaine SP
    Liver Transpl; 2001 Aug; 7(8):745-9. PubMed ID: 11510023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
    Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
    Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension.
    Minder S; Fischler M; Muellhaupt B; Zalunardo MP; Jenni R; Clavien PA; Speich R
    Eur Respir J; 2004 Oct; 24(4):703-7. PubMed ID: 15459152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
    Kato H; Katori T; Nakamura Y; Kawarasaki H
    Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portopulmonary hypertension and the liver transplant candidate.
    Kuo PC; Plotkin JS; Gaine S; Schroeder RA; Rustgi VK; Rubin LJ; Johnson LB
    Transplantation; 1999 Apr; 67(8):1087-93. PubMed ID: 10232556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perioperative management of living-donor liver transplantation in two patients with severe portopulmonary hypertension].
    Tominaga M; Furutani H; Segawa H; Shoda T; Mima H; Adachi T; Fukuda K
    Masui; 2003 Jul; 52(7):729-32. PubMed ID: 12910972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of treatment of portopulmonary hypertension on survival following liver transplantation.
    Ashfaq M; Chinnakotla S; Rogers L; Ausloos K; Saadeh S; Klintmalm GB; Ramsay M; Davis GL
    Am J Transplant; 2007 May; 7(5):1258-64. PubMed ID: 17286619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series.
    Sussman N; Kaza V; Barshes N; Stribling R; Goss J; O'Mahony C; Zhang E; Vierling J; Frost A
    Am J Transplant; 2006 Sep; 6(9):2177-82. PubMed ID: 16796721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
    Halank M; Kolditz M; Miehlke S; Schiemanck S; Schmeisser A; Hoeffken G
    Wien Med Wochenschr; 2005 Aug; 155(15-16):376-80. PubMed ID: 16160926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epoprostenol in the treatment of portopulmonary hypertension].
    Culafić D; Culafić-Vojinović V; Jesić R
    Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for severe portopulmonary hypertension in a child allows for liver transplantation.
    Serrano RM; Subbarao GC; Mangus RS; Montgomery G; Johansen M
    Pediatr Transplant; 2019 Aug; 23(5):e13461. PubMed ID: 31062925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis.
    Molnar C; Alber H; Colleselli D; Vogel W; Kähler CM
    Wien Klin Wochenschr; 2004 Sep; 116(17-18):627-30. PubMed ID: 15515882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
    Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
    Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.